Towards Healthcare
U.S. Life Science Market Forecast 2025 to 2034 Trends & Revenue Outlook

U.S. Life Science Market 2025 Insights Biopharma Dominance, CRO/CDMO Surge & Precision Medicine Boom

The U.S. life science market is growing strong due to the rising demand for biologics.

  • Insight Code: 6001
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The U.S. life science market projected to generate hundreds of millions in revenue by 2034, fueled by innovation and evolving consumer demands.

The U.S. life science market includes 2 segments such as by product/service and by region.

Some key players include Johnson & Johnson, Eli Lilly, AbbVie, Amgen, Thermo Fisher Scientific, etc.

Key trends include rising investment in pharmaceutical and biotechnology companies.

National Institutes of Health, FDA, WHO, CDC.